Location: West Hollywood, CA
CIK: 0002013341 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $331M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | 2,221,474 | $92.24M | 27.9% | $34.21 | +21.0% | COM | 156944100 |
| RAPT | RAPT Therapeutics, Inc. | 1,562,500 | $52.92M | 16.0% | $7.63 | +307.1% | COM | 75382E208 |
| ALMS | ALUMIS INC. | 4,247,670 | $41.46M | 12.5% | $9.97 | -30.0% | COM | 022307102 |
| CNTA | Centessa Pharmaceuticals plc | 1,364,019 | $34.11M | 10.3% | $17.39 | — | SPONSORED ADS | 152309100 |
| VSTM | Verastem, Inc. | 3,135,120 | $24.2M | 7.3% | $7.21 | +23.7% | COM | 92337C203 |
| DNLI | Denali Therapeutics Inc. | 1,000,000 | $16.51M | 5.0% | $14.37 | +17.5% | COM | 24823R105 |
| NTRA | Natera, Inc. | 67,356 | $15.43M | 4.7% | $208.59 | 0.0% | COM | 632307104 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | 530,000 | $14.43M | 4.4% | $35.08 | 0.0% | COM | 00847X104 |
| KYMR | Kymera Therapeutics, Inc. | 146,332 | $11.39M | 3.4% | $45.17 | +49.5% | COM | 501575104 |
| — | Atai Beckley N.V. | 2,750,000 | $11.25M | 3.4% | $4.09 | — | SHS | N0731H103 |
| CRVS | Corvus Pharmaceuticals, Inc. | 1,381,233 | $10.64M | 3.2% | $7.13 | +10.5% | COM | 221015100 |
| HNGE | Hinge Health, Inc. | 135,000 | $6.271M | 1.9% | $40.42 | +19.1% | CL A | 433313103 |